Shares of Moderna, Novavax, Pfizer, BioNTech and GSK closed lower on Thursday. Shares of vaccine makers fell on Thursday on ...

Analysts have set 12-month price targets for BioNTech, revealing an average target of $132.24, a high estimate of $171.00, ...

November 13th has seen a myriad of significant events throughout history, impacting various spheres such as politics, science ...

Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...

The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

The Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its ...

Findings highlight the Pfizer-BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in ...

A Winchester man who participated in a multi-state drug trafficking operation will be released from prison later this month ...

The Centers for Disease Control and Prevention (CDC) recommends the Moderna and Pfizer-BioNTech COVID-19 vaccines for kids as ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...